2024-04-012025-03-312025-03-31false08466919DENTAL STUDIO 19 LTD2025-12-30falseiso4217:GBPxbrli:pure084669192024-03-31084669192025-03-31084669192024-04-012025-03-31084669192023-03-31084669192024-03-31084669192023-04-012024-03-3108466919bus:SmallEntities2024-04-012025-03-3108466919bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3108466919bus:FullAccounts2024-04-012025-03-3108466919bus:PrivateLimitedCompanyLtd2024-04-012025-03-3108466919core:WithinOneYear2025-03-3108466919core:AfterOneYear2025-03-3108466919core:WithinOneYear2024-03-3108466919core:AfterOneYear2024-03-3108466919core:ShareCapital2025-03-3108466919core:SharePremium2025-03-3108466919core:RevaluationReserve2025-03-3108466919core:OtherReservesSubtotal2025-03-3108466919core:RetainedEarningsAccumulatedLosses2025-03-3108466919core:ShareCapital2024-03-3108466919core:SharePremium2024-03-3108466919core:RevaluationReserve2024-03-3108466919core:OtherReservesSubtotal2024-03-3108466919core:RetainedEarningsAccumulatedLosses2024-03-3108466919core:LandBuildings2025-03-3108466919core:PlantMachinery2025-03-3108466919core:Vehicles2025-03-3108466919core:FurnitureFittings2025-03-3108466919core:OfficeEquipment2025-03-3108466919core:NetGoodwill2025-03-3108466919core:IntangibleAssetsOtherThanGoodwill2025-03-3108466919core:ListedExchangeTraded2025-03-3108466919core:UnlistedNon-exchangeTraded2025-03-3108466919core:LandBuildings2024-03-3108466919core:PlantMachinery2024-03-3108466919core:Vehicles2024-03-3108466919core:FurnitureFittings2024-03-3108466919core:OfficeEquipment2024-03-3108466919core:NetGoodwill2024-03-3108466919core:IntangibleAssetsOtherThanGoodwill2024-03-3108466919core:ListedExchangeTraded2024-03-3108466919core:UnlistedNon-exchangeTraded2024-03-3108466919core:LandBuildings2024-04-012025-03-3108466919core:PlantMachinery2024-04-012025-03-3108466919core:Vehicles2024-04-012025-03-3108466919core:FurnitureFittings2024-04-012025-03-3108466919core:OfficeEquipment2024-04-012025-03-3108466919core:NetGoodwill2024-04-012025-03-3108466919core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3108466919core:ListedExchangeTraded2024-04-012025-03-3108466919core:UnlistedNon-exchangeTraded2024-04-012025-03-3108466919core:MoreThanFiveYears2024-04-012025-03-3108466919core:Non-currentFinancialInstruments2025-03-3108466919core:Non-currentFinancialInstruments2024-03-3108466919dpl:CostSales2024-04-012025-03-3108466919dpl:DistributionCosts2024-04-012025-03-3108466919core:LandBuildings2024-04-012025-03-3108466919core:PlantMachinery2024-04-012025-03-3108466919core:Vehicles2024-04-012025-03-3108466919core:FurnitureFittings2024-04-012025-03-3108466919core:OfficeEquipment2024-04-012025-03-3108466919dpl:AdministrativeExpenses2024-04-012025-03-3108466919core:NetGoodwill2024-04-012025-03-3108466919core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3108466919dpl:GroupUndertakings2024-04-012025-03-3108466919dpl:ParticipatingInterests2024-04-012025-03-3108466919dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3108466919core:ListedExchangeTraded2024-04-012025-03-3108466919dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3108466919core:UnlistedNon-exchangeTraded2024-04-012025-03-3108466919dpl:CostSales2023-04-012024-03-3108466919dpl:DistributionCosts2023-04-012024-03-3108466919core:LandBuildings2023-04-012024-03-3108466919core:PlantMachinery2023-04-012024-03-3108466919core:Vehicles2023-04-012024-03-3108466919core:FurnitureFittings2023-04-012024-03-3108466919core:OfficeEquipment2023-04-012024-03-3108466919dpl:AdministrativeExpenses2023-04-012024-03-3108466919core:NetGoodwill2023-04-012024-03-3108466919core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3108466919dpl:GroupUndertakings2023-04-012024-03-3108466919dpl:ParticipatingInterests2023-04-012024-03-3108466919dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3108466919core:ListedExchangeTraded2023-04-012024-03-3108466919dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3108466919core:UnlistedNon-exchangeTraded2023-04-012024-03-3108466919core:NetGoodwill2025-03-3108466919core:IntangibleAssetsOtherThanGoodwill2025-03-3108466919core:LandBuildings2025-03-3108466919core:PlantMachinery2025-03-3108466919core:Vehicles2025-03-3108466919core:FurnitureFittings2025-03-3108466919core:OfficeEquipment2025-03-3108466919core:AfterOneYear2025-03-3108466919core:WithinOneYear2025-03-3108466919core:ListedExchangeTraded2025-03-3108466919core:UnlistedNon-exchangeTraded2025-03-3108466919core:ShareCapital2025-03-3108466919core:SharePremium2025-03-3108466919core:RevaluationReserve2025-03-3108466919core:OtherReservesSubtotal2025-03-3108466919core:RetainedEarningsAccumulatedLosses2025-03-3108466919core:NetGoodwill2024-03-3108466919core:IntangibleAssetsOtherThanGoodwill2024-03-3108466919core:LandBuildings2024-03-3108466919core:PlantMachinery2024-03-3108466919core:Vehicles2024-03-3108466919core:FurnitureFittings2024-03-3108466919core:OfficeEquipment2024-03-3108466919core:AfterOneYear2024-03-3108466919core:WithinOneYear2024-03-3108466919core:ListedExchangeTraded2024-03-3108466919core:UnlistedNon-exchangeTraded2024-03-3108466919core:ShareCapital2024-03-3108466919core:SharePremium2024-03-3108466919core:RevaluationReserve2024-03-3108466919core:OtherReservesSubtotal2024-03-3108466919core:RetainedEarningsAccumulatedLosses2024-03-3108466919core:NetGoodwill2023-03-3108466919core:IntangibleAssetsOtherThanGoodwill2023-03-3108466919core:LandBuildings2023-03-3108466919core:PlantMachinery2023-03-3108466919core:Vehicles2023-03-3108466919core:FurnitureFittings2023-03-3108466919core:OfficeEquipment2023-03-3108466919core:AfterOneYear2023-03-3108466919core:WithinOneYear2023-03-3108466919core:ListedExchangeTraded2023-03-3108466919core:UnlistedNon-exchangeTraded2023-03-3108466919core:ShareCapital2023-03-3108466919core:SharePremium2023-03-3108466919core:RevaluationReserve2023-03-3108466919core:OtherReservesSubtotal2023-03-3108466919core:RetainedEarningsAccumulatedLosses2023-03-3108466919core:AfterOneYear2024-04-012025-03-3108466919core:WithinOneYear2024-04-012025-03-3108466919core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3108466919core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3108466919core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3108466919core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3108466919core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3108466919core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3108466919core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3108466919core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3108466919core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3108466919core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3108466919core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3108466919core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3108466919core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3108466919core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3108466919core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3108466919core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3108466919core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3108466919core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3108466919core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3108466919core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3108466919core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3108466919core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3108466919core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3108466919core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3108466919core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3108466919core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3108466919core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3108466919bus:Director12024-04-012025-03-3108466919core:FurnitureFittingsToolsEquipment2024-03-3108466919core:FurnitureFittingsToolsEquipment2024-04-012025-03-3108466919core:FurnitureFittingsToolsEquipment2025-03-31

DENTAL STUDIO 19 LTD

Registered Number
08466919
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

DENTAL STUDIO 19 LTD
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

Odette Agnes Lazarus

Company Secretary

Odette Agnes Lazarus

Registered Address

19 Bell Street
Sawbridgeworth
CM21 9AR

Registered Number

08466919 (England and Wales)
DENTAL STUDIO 19 LTD
Statement of Financial Position
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets311,472948
11,472948
Current assets
Debtors5127,608173,239
Cash at bank and on hand66,13932,834
193,747206,073
Creditors amounts falling due within one year6(31,655)(10,292)
Net current assets (liabilities)162,092195,781
Total assets less current liabilities173,564196,729
Creditors amounts falling due after one year7(9,514)-
Provisions for liabilities9(2,800)(224)
Net assets161,250196,505
Capital and reserves
Called up share capital100100
Profit and loss account161,150196,405
Shareholders' funds161,250196,505
The financial statements were approved and authorised for issue by the Director on 30 December 2025, and are signed on its behalf by:
Odette Agnes Lazarus
Director
Registered Company No. 08466919
DENTAL STUDIO 19 LTD
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number is 08466919 and registered office address is 19 Bell Street, Sawbridgeworth, Hertfordshire, CM21 9AR.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts. Turnover includes revenue earned from the rendering of services.
Revenue from rendering of services
Revenue from the rendering of dental services is recognised by reference to the stage of completion at the reporting date. This is typically determined based on the date the service is performed. For longer-term treatment plans, revenue is recognised based on the proportion of services delivered up to the reporting date, where the outcome can be reliably estimated. Where the outcome of a course of treatment cannot be estimated reliably, revenue is recognised only to the extent that the expenses incurred are recoverable. As the company is not registered for VAT, revenue is stated inclusive of any VAT charged to patients.
Finance costs
Finance costs charged to the profit or loss include interest expense calculated using the effective interest method from FRS 102:11, finance charges on finance leases, and exchange differences on foreign currency borrowings where these are treated as an adjustment to interest costs.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Plant and machinery4
Fixtures and fittings4
Office Equipment4
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised. Debt instruments are subsequently carried at amortised cost, using the effective interest rate method. Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
2.Average number of employees

20252024
Average number of employees during the year11
3.Tangible fixed assets

Plant & machinery

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 April 24--1,4021,402
Additions33,322503-33,825
At 31 March 2533,3225031,40235,227
Depreciation and impairment
At 01 April 24--454454
Charge for year22,8628835123,301
At 31 March 2522,8628880523,755
Net book value
At 31 March 2510,46041559711,472
At 31 March 24--948948
4.Impairment of tangible fixed assets
At each reporting date, the company assesses whether there is any indication that tangible fixed assets may be impaired. If such indication exists, the recoverable amount of the asset (or asset group) is estimated and compared with its carrying amount. Where the carrying amount exceeds the recoverable amount, the asset is written down to its recoverable amount and an impairment loss is recognised in the profit and loss account. Any subsequent reversal of an impairment loss is recognised immediately in the profit and loss account to the extent that the revised carrying amount does not exceed the carrying amount that would have been determined had no impairment been recognised.
5.Debtors: amounts due within one year

2025

2024

££
Other debtors127,608173,239
Total127,608173,239
As at balance sheet date of March 2025, the other debtors comprise the following : Prepayments: £676 Intercompany Loan account: £126,932.08
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables2,990-
Taxation and social security18,56210,087
Finance lease and HP contracts9,837-
Other creditors266205
Total31,65510,292
As at the balance sheet date of 31 March 2025, other creditors comprise the following: Director's loan account: £265
7.Creditors: amounts due after one year

2025

2024

££
Other creditors9,514-
Total9,514-
8.Obligations under finance leases

2025

2024

££
Finance lease and HP contracts19,351-
9.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)2,800224
Total2,800224
10.Share capital
Authorised share capital: The company has authorised ordinary shares as follows: Ordinary Shares: 99 @ £1 each, Ordinary Share Capital B: 1 @ £1 each. As of 31 March 2025, the total ordinary share capital remains at £100, consistent with the previous year.
11.Related party transactions
As at 31 March 2025, the company had balances with related parties as follows: Dentistry 19 Ltd: £126,932.08 (2024: £172,492) All outstanding balances with related parties are unsecured, interest-free, and have no fixed date for repayment. No guarantees have been given or received in respect of these balances